{"x402Version":2,"network":"base-mainnet","networks":["base-mainnet","solana-mainnet"],"asset":"USDC","accuracy":"https://api.biotechcatalystsentinel.com/v1/accuracy","resources":[{"method":"GET","path":"/v1/catalysts/upcoming","price":"$0.02","accepts":["base","solana"],"url":"https://api.biotechcatalystsentinel.com/v1/catalysts/upcoming","description":"Upcoming FDA drug-approval (PDUFA) decision dates for US-listed biotechs — a forward catalyst calendar extracted from primary SEC 8-K/6-K filings, every date grounded in a verbatim filing quote and cited to its EDGAR accession. The difference from other catalyst feeds: each date is scored against the actual FDA decision, so accuracy is a public, auditable track record (median 1-day error) — verify it free at GET /v1/accuracy before you pay.","input_example":{"within_days":365,"limit":200},"output_example":{"data":[{"drug_name":"ONS-5010/LYTENAVA (bevacizumab-vikg)","company":"Outlook Therapeutics, Inc.","ticker":"OTLK","tickers":["OTLK"],"indication":"wet AMD","pdufa_date":"2026-07-29","stage":"set","confidence":"high","source_url":"https://www.sec.gov/Archives/edgar/data/1649989/..."}],"meta":{"total":1}}},{"method":"GET","path":"/v1/events","price":"$0.05","accepts":["base","solana"],"url":"https://api.biotechcatalystsentinel.com/v1/events","description":"FDA drug-approval catalyst change stream for US-listed biotechs: every state change of every catalyst we track — each PDUFA date as it is set, extended and resolved — with the real outcome (approval, or CRL/rejection), the SEC filing quote and its EDGAR source. A superset of the upcoming calendar, as a since-cursor delta feed. Date accuracy AND our coverage of the FDA universe are both published free and unflattered at GET /v1/accuracy — audit before you pay.","input_example":{"since":0,"limit":100},"output_example":{"data":[{"event_id":412,"catalyst_id":88,"event_type":"decision_outcome","drug_name":"ONS-5010/LYTENAVA (bevacizumab-vikg)","company":"Outlook Therapeutics, Inc.","ticker":"OTLK","tickers":["OTLK"],"indication":"wet AMD","application_number":"BLA761334","prior_date":null,"new_date":"2025-08-27","new_date_upcoming":false,"days_to_date":null,"delta_days":null,"outcome":"approved","confidence":"high","date_confidence":"confirmed","authority":"llm_high","source_quote":"the FDA has approved LYTENAVA (bevacizumab-vikg) ...","detected_at":"2025-08-27T00:00:00","accession":"0001649989-25-000123","source_url":"https://www.sec.gov/Archives/edgar/data/1649989/..."}],"meta":{"total":1}}}]}